Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-10090-01297
Entry Name
UniProt Accession
Theoretical PI
7.28
Molecular Weight
71982.85
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
Tumor necrosis factor receptor superfamily member 21
Protein Synonyms/Alias
Death receptor 6; CD358;
Gene Name
Tnfrsf21
Gene Synonyms/Alias
Dr6;
Created Date
27-MAY-2002
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
368
Canonical
VLVLIVVCSIRKSSR
[1]
S-Palmitoylation
Organism
Mus musculus (Mouse)
NCBI Taxa ID
10090
Reference
[1] Klíma M, Zájedová J, Doubravská L, Andera L. Functional analysis of theposttranslational modifications of the death receptor 6. Biochim Biophys Acta.2009 Oct;1793(10):1579-87. doi: 10.1016/j.bbamcr.2009.07.008. Epub 2009 Aug 3.[PMID:19654028]
Functional Description
Promotes apoptosis, possibly via a pathway that involves the activation of NF-kappa-B. Can also promote apoptosis mediated by BAX and by the release of cytochrome c from the mitochondria into the cytoplasm. Plays a role in neuronal apoptosis, including apoptosis in response to amyloid peptides derived from APP, and is required for both normal cell body death and axonal pruning. Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to release sAPP-beta which is further cleaved to release an N-terminal fragment of APP (N-APP). N-APP binds TNFRSF21; this triggers caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase- 6). Negatively regulates oligodendrocyte survival, maturation and myelination. Plays a role in signaling cascades triggered by stimulation of T-cell receptors, in the adaptive immune response and in the regulation of T-cell differentiation and proliferation. Negatively regulates T-cell responses and the release of cytokines such as IL4, IL5, IL10, IL13 and IFNG by Th2 cells. Negatively regulates the production of IgG, IgM and IgM in response to antigens. May inhibit the activation of JNK in response to T-cell stimulation.
Sequence Annotation
Topological domain: 42 349 Extracellular.
Transmembrane: 350 370 Helical.
Topological domain: 371 655 Cytoplasmic.
Domain: 415 498 Death.
Protein Length
655 AA.
Protein Sequence
(Canonical)
MGTRASSITA LASCSRTAGQ VGATMVAGSL LLLGFLSTIT AQPEQKTLSL PGTYRHVDRT  60
TGQVLTCDKC PAGTYVSEHC TNMSLRVCSS CPAGTFTRHE NGIERCHDCS QPCPWPMIER  120
LPCAALTDRE CICPPGMYQS NGTCAPHTVC PVGWGVRKKG TENEDVRCKQ CARGTFSDVP  180
SSVMKCKAHT DCLGQNLEVV KPGTKETDNV CGMRLFFSST NPPSSGTVTF SHPEHMESHD  240
VPSSTYEPQG MNSTDSNSTA SVRTKVPSGI EEGTVPDNTS STSGKEGTNR TLPNPPQVTH  300
QQAPHHRHIL KLLPSSMEAT GEKSSTAIKA PKRGHPRQNA HKHFDINEHL PWMIVLFLLL  360
VLVLIVVCSI RKSSRTLKKG PRQDPSAIVE KAGLKKSLTP TQNREKWIYY RNGHGIDILK  420
LVAAQVGSQW KDIYQFLCNA SEREVAAFSN GYTADHERAY AALQHWTIRG PEASLAQLIS  480
ALRQHRRNDV VEKIRGLMED TTQLETDKLA LPMSPSPLSP SPMPSPNVKL ENSTLLTVEP  540
SPLDKNKCFF VDESEPLLRC DSTSSGSSAL SRNGSFITKE KKDTVLRQVR LDPCDLQPIF  600
DDMLHILNPE ELRVIEEIPQ AEDKLDRLFE IIGVKSQEAS QTLLDSVYSH LPDLL       655
FASTA
(Canonical)
>LipidDB-10090-01297|Q9EPU5
MGTRASSITALASCSRTAGQVGATMVAGSLLLLGFLSTITAQPEQKTLSLPGTYRHVDRT
TGQVLTCDKCPAGTYVSEHCTNMSLRVCSSCPAGTFTRHENGIERCHDCSQPCPWPMIER
LPCAALTDRECICPPGMYQSNGTCAPHTVCPVGWGVRKKGTENEDVRCKQCARGTFSDVP
SSVMKCKAHTDCLGQNLEVVKPGTKETDNVCGMRLFFSSTNPPSSGTVTFSHPEHMESHD
VPSSTYEPQGMNSTDSNSTASVRTKVPSGIEEGTVPDNTSSTSGKEGTNRTLPNPPQVTH
QQAPHHRHILKLLPSSMEATGEKSSTAIKAPKRGHPRQNAHKHFDINEHLPWMIVLFLLL
VLVLIVVCSIRKSSRTLKKGPRQDPSAIVEKAGLKKSLTPTQNREKWIYYRNGHGIDILK
LVAAQVGSQWKDIYQFLCNASEREVAAFSNGYTADHERAYAALQHWTIRGPEASLAQLIS
ALRQHRRNDVVEKIRGLMEDTTQLETDKLALPMSPSPLSPSPMPSPNVKLENSTLLTVEP
SPLDKNKCFFVDESEPLLRCDSTSSGSSALSRNGSFITKEKKDTVLRQVRLDPCDLQPIF
DDMLHILNPEELRVIEEIPQAEDKLDRLFEIIGVKSQEASQTLLDSVYSHLPDLL
Gene Ontology
GO:0030424; C:axon; IDA:UniProtKB
GO:0005887; C:integral component of plasma membrane; IEA:Ensembl
GO:0031226; C:intrinsic component of plasma membrane; IDA:UniProtKB
GO:0002250; P:adaptive immune response; IMP:UniProtKB
GO:0001783; P:B cell apoptotic process; IMP:UniProtKB
GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
GO:0006959; P:humoral immune response; IMP:UniProtKB
GO:0042552; P:myelination; IMP:UniProtKB
GO:0030889; P:negative regulation of B cell proliferation; IMP:UniProtKB
GO:2001180; P:negative regulation of interleukin-10 secretion; IMP:UniProtKB
GO:2000666; P:negative regulation of interleukin-13 secretion; IMP:UniProtKB
GO:2000663; P:negative regulation of interleukin-5 secretion; IMP:UniProtKB
GO:0031642; P:negative regulation of myelination; IEA:Ensembl
GO:0042130; P:negative regulation of T cell proliferation; IMP:UniProtKB
GO:0051402; P:neuron apoptotic process; IMP:UniProtKB
GO:0097252; P:oligodendrocyte apoptotic process; IMP:UniProtKB
GO:0048713; P:regulation of oligodendrocyte differentiation; IMP:UniProtKB
GO:0050852; P:T cell receptor signaling pathway; IMP:UniProtKB
Interpro
InterPro; IPR011029; DEATH-like_dom
InterPro; IPR000488; Death_domain
InterPro; IPR001368; TNFR/NGFR_Cys_rich_reg
InterPro; IPR022330; TNFR_21
Pfam
Pfam; PF00531; Death;
SMART
SMART; SM00005; DEATH;
SMART; SM00208; TNFR;
PROSITE
PROSITE; PS50017; DEATH_DOMAIN;
PROSITE; PS00652; TNFR_NGFR_1;
PROSITE; PS50050; TNFR_NGFR_2;
PRINTS
PRINTS; PR01971; TNFACTORR21;